Bokf, Na Horizon Therapeutics Public LTD CO Transaction History

Bokf, Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 21, 2023	SELL	$96.34 - $112.38 $34,200 - $39,894	-355 Reduced 72.45%	135 $13,000
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $52,586 - $55,615	490 New	490 $53,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $165,062 - $209,737	-1,910 Closed	0 $0
Q4 2021 Mar 11, 2022	SELL	$98.56 - $119.91 $50,364 - $61,274	-511 Reduced 21.11%	1,910 $206,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $222,514 - $267,205	2,421 New	2,421 $265,000

Q1 2021 Apr 21, 2021	SELL	$71.83 - $95.48 $328,981 - $437,298	-4,580 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $306,860 - $386,506	4,580 New	4,580 $335,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.